Patents by Inventor Johan Wannberg

Johan Wannberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PIPERIDINYL BENZOIMIDAZOLE DERIVATIVES AS MPGE-1 INHIBITORS
    Publication number: 20160122330
    Abstract: The compounds (R)-1-(5-chloro-6-methyl-1-(6-(trifluoromethyl)pyridin-2-yl)-1H-benzo[d]imidazol-2-yl)-N-(tetrahydrofuran-3-yl)piperidine-4-carboxamide and (R)-1-(6-chloro-1-methyl-1-(6-(trifluoromethyl)pyridin-2-yl)-1H-benzo[d]imidazol-2-yl)-N-(tetrahydrofuran-3-yl)piperidine-4-carboxamide, as well as pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising any one of these compounds. The compounds are useful for the treatment and/or prevention of a disorder selected from an inflammatory disease; an autoimmune disease; pain; a breathing disorder; cancer; a cardiovascular disease; a neurodegenerative disease; a bone disease; a disorder due to familial adenomatous polyposis (FAP) condition; overactive bladder; fever; and inflammation-related anorexia.
    Type: Application
    Filed: June 20, 2013
    Publication date: May 5, 2016
    Inventor: Johan WANNBERG
  • Quinoline derivatives and their use as tyrosine kinase inhibitors
    Patent number: 8957092
    Abstract: A compound of formula 6-(methylcarbamoyl)-4-[(4-methylphenyl)amino]quinoline-3-carboxylic acid, and pharmaceutically acceptable salts thereof, is provided. The compound can be used to treat cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema and psoriasis.
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: February 17, 2015
    Assignee: ClanoTech AB
    Inventors: Jacob Westman, Natalia Nekhotiaeva, Johan Wannberg, Ulrika Backman, Johan Malm
  • QUINOLINE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS
    Publication number: 20140018388
    Abstract: A compound of formula 6-(methylcarbamoyl)-4-[(4-methylphenyl)amino]quinoline-3-carboxylic acid, and pharmaceutically acceptable salts thereof, is provided. The compound can be used to treat cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema and psoriasis.
    Type: Application
    Filed: August 30, 2013
    Publication date: January 16, 2014
    Applicant: Clano Tech AB
    Inventors: Jacob WESTMAN, Natalia NEKHOTIAEVA, Johan WANNBERG, Ulrika BACKMAN, Johan MALM
  • Quinoline derivatives and their use as tyrosine kinase inhibitors
    Patent number: 8557843
    Abstract: A compound of formula (I) as well as pharmaceutically acceptable salts thereof. A pharmaceutical composition having a therapeutically effective amount of the compound. The compound is useful for the treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema or psoriasis.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: October 15, 2013
    Assignee: ClanoTech AB
    Inventors: Jacob Westman, Natalia Nekhotiaeva, Johan Wannberg, Ulrika Backman, Johan Malm
  • QUINOLINE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS
    Publication number: 20110053976
    Abstract: A compound of formula (I) as well as pharmaceutically acceptable salts thereof. A pharmaceutical composition having a therapeutically effective amount of the compound. The compound is useful for the treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema or psoriasis.
    Type: Application
    Filed: November 14, 2008
    Publication date: March 3, 2011
    Applicant: CLANOTECH AB
    Inventors: Jacob Westman, Natalia Nekhotiaeva, Johan Wannberg, Ulrika Backman, Johan Malm
  • COMPOUNDS AND METHODS
    Publication number: 20100324086
    Abstract: A compound of formula (1) as well as pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising the compound. The compound is useful for the treatment of disorder from pain, fever, inflammation and cancer.
    Type: Application
    Filed: February 19, 2009
    Publication date: December 23, 2010
    Applicant: Novasaid AB
    Inventors: Johan Wannberg, Mathias Alterman, Patric Stenberg, Jacob Westman